This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Key techniques include high-throughput screening (HTS), cell-basedassays, and animal models. Cell-BasedAssays In vitro, drug efficacy, and toxicity testing in cell cultures provide valuable preclinical data.
I would argue that the L2021 study has absolutely no relevance whatsoever to the selection of compounds for development since the team will have data available that enables them to rule out the vast majority of the project compounds for nomination.
ASLAN003 is a highly selective and potent inhibitor of human DHODH (IC 50 = 35 nM) and has been shown to be more than 30 times more potent at inhibiting the DHODH enzyme in cell free and cell-basedassays than the first generation inhibitor teriflunomide.
Janne’s passion for the topic of ethics and the future of AI has led her to attend conferences and events to build her knowledge as an attendee and be invited to panels and fireside chats to discuss. From small start-ups through to big pharma, Janne’s experience covers it all.
In measuring cell viability, membrane integrity is a key indicator, as only viable cells with intact membranes are counted as living. Next to cell viability assays, cell-basedassays can also be employed to analyse other cellular events like cytotoxicity, reactive oxygen species (ROS) production or cell metabolism.
In this blog, we highlight some of the solutions available for researchers to tackle atherosclerotic vascular disease: from fundamental research rooted in ischemia-reperfusion studies and cell-basedassays to drug discovery efforts and the early detection of drug-related side effects. What is atherosclerotic vascular disease?
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content